L Capital Partners overview
Stories about L Capital Partners
PE Firms Take Stake in Pepe Jeans
Arta Capital and L Capital Partners have agreed to acquire a 27.9% stake in Pepe Jeans, for €85 million. Sellers include Spanish private equity firm Torreal and Pepe management, which will end up holding 31% and 30% of the company, respectively.
CeNeRx Raises $9 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $4 million in Series C funding from return backers Aisling Capital, L Capital Partners and Pappas Ventures. It also secured a $5 million credit facility from MidCap Financial.
CeNeRx BioPharma Raises $15 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $15 million in Series B funding. Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.
L Capital Partners funds managed
Closed funds: 1
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close date- | Strategy | |
Stories that mention L Capital Partners
Choosy Shoppers
Despite poor VC returns, limited partners are still interested in venture capital. They are just more selective about where they place their money.
Week in deals, Aug. 16, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
CeNeRx BioPharma Raises $13 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $13 million in new Series C funding (including $3m in debt). Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.
peHUB Wire: Friday, August 13, 2010
Random Ramblings
peHUB Wire: Friday, August 13, 2010
Random Ramblings
peHUB Wire: Thursday, August 12, 2010
Are PE Firms Living Up To ILPA Principles?
peHUB Wire: Thursday, August 12, 2010
Are PE Firms Living Up To ILPA Principles?